FIBROGEN INC·4

Feb 23, 8:29 PM ET

Conterno Enrique A 4

4 · FIBROGEN INC · Filed Feb 23, 2023

Insider Transaction Report

Form 4
Period: 2023-02-21
Conterno Enrique A
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-02-21+85,300380,783 total
  • Award

    Stock Option (Right to Buy)

    2023-02-21+143,100143,100 total
    Exercise: $22.60Exp: 2033-02-20Common Stock (143,100 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    27,800
Footnotes (2)
  • [F1]Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
  • [F2]Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION